Avalyn Pharma is hoping to rake in around $181.8 million from an IPO, which the biotech will use to take its inhaled versions of approved drugs for respiratory conditions into late-stage studies.
Avalyn Pharma is hoping to rake in around $181.8 million from an IPO, which the biotech will use to take its inhaled versions of approved drugs for respiratory conditions into late-stage studies.
يعود تقليد قديم إلى الواجهة في العصر الحديث، إذ يقصد الناس الساونا والحمامات منذ قرون لفوائدها الصحية، ومع تراجع الإقبال على تناول المشروبات الكحولية، يتجهون لوسائل …
Thousands of patients will be offered a new injectable form of an immunotherapy drug that takes minutes.
The World Health Organization says that a suspected hantavirus outbreak on a cruise ship in the Atlantic Ocean has killed three people and sickened at least …
U.S. Africa Command (Africom) on Sunday said two U.S. service members participating in a military exercise missing in Morocco. “The incident remains under investigation and the …